TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Swetrade Pharmaceuticals AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,688
|
2,440
|
1,836 |
Financial expenses |
0
|
45
|
0 |
Earnings before taxes |
137
|
90
|
147 |
EBITDA |
134
|
41
|
147 |
Total assets |
1,950
|
2,110
|
1,756 |
Current assets |
1,825
|
1,985
|
1,586 |
Current liabilities |
371
|
667
|
391 |
Equity capital |
988
|
852
|
762 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
50.7%
|
40.4%
|
43.4% |
Turnover per employee |
1,344
|
1,220
|
918 |
Profit as a percentage of turnover |
5.1%
|
3.7%
|
8.0% |
Return on assets (ROA) |
7.0%
|
6.4%
|
8.4% |
Current ratio |
491.9%
|
297.6%
|
405.6% |
Return on equity (ROE) |
13.9%
|
10.6%
|
19.3% |
Change turnover |
248
|
604
|
-445 |
Change turnover % |
10%
|
33%
|
-20% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.